Intellia Therapeutics (NTLA) FCF Margin (QoQ) (2015 - 2026)
Intellia Therapeutics (NTLA) FCF Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Intellia Therapeutics | 1.67 Bn | 1.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32,845.00 |
| Mar 31, 2026 | -47,825.00 |
| Dec 31, 2025 | 26,368.00 |
| Sep 30, 2025 | 13,353.00 |
| Jun 30, 2025 | 19,743.00 |
| Mar 31, 2025 | -23,287.00 |
| Dec 31, 2024 | 26,499.00 |
| Sep 30, 2024 | -11,891.00 |
| Jun 30, 2024 | -38,374.00 |
| Mar 31, 2024 | -470,914.00 |
| Dec 31, 2023 | 516,499.00 |
| Sep 30, 2023 | -18,320.00 |
| Jun 30, 2023 | 19,690.00 |
| Mar 31, 2023 | -23,722.00 |
| Dec 31, 2022 | -7,791.00 |
| Sep 30, 2022 | 2,660.00 |
| Jun 30, 2022 | 13,559.00 |
| Mar 31, 2022 | -29,481.00 |
| Dec 31, 2021 | 51,810.00 |
| Sep 30, 2021 | -8,878.00 |